About this Event
Virtual Event
This presentation includes a review and discussions of Warning Letters for Principal Investigators (Clinical Investigators), Sponsor-Investigators and Institutional Review Boards issued by the FDA during the past three months.
Event Details
3 people are interested in this event
User Activity
No recent activity
